정형외과용 바이오소재 시장 : 재료 유형별, 용도별, 지역별(2025-2033년)

The global orthopedic biomaterials market size reached USD 19.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.3 Billion by 2033, exhibiting a growth rate (CAGR) of 8.85% during 2025-2033. The rising geriatric population, rapid product innovations, significant growth in the healthcare industry, the implementation of various government initiatives, and extensive research and development (R&D) activities are some of the key factors driving the market.

Orthopedic biomaterials are substances used in orthopedic surgery to replace or repair damaged bone or joint tissues. They are either synthetic or natural and are designed to mimic the properties of bone and joint tissues. Ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites are some of the common types of materials. Orthopedic biomaterials are widely used for joint replacement surgeries, such as hip, knee, and shoulder replacements, fracture fixations, spinal implants, bone grafting, and soft tissue repair. They exhibit high strength, ductility, fracture toughness, hardness, corrosion resistance, formability, and biocompatibility.

Orthopedic Biomaterials Market Trends:

The rising geriatric population across the globe prone to the risk of various musculoskeletal disorders, such as osteoarthritis, osteoporosis, and fractures is one of the key factors propelling the market growth. In line with this, the increasing prevalence of orthopedic conditions and injuries, such as sports injuries, degenerative joint diseases, and traumatic fractures, is favoring the market growth. Moreover, the growing awareness about orthopedic disorders and the availability of advanced treatment solutions is acting as another growth-inducing factor. Apart from this, the introduction of advanced biomaterials that offer enhanced biocompatibility, durability, mechanical strength, and integration with natural tissues, improving the success rates and longevity of orthopedic implants, is providing an impetus to the market growth. Additionally, the utilization of biodegradable materials that are derived from natural sources and are used in orthopedics to promote tissue regeneration and healing is contributing to the market growth. Furthermore, the increasing demand for minimally invasive (MI) surgeries due to their advantages, such as smaller incisions, faster recovery, reduced pain, and shorter hospital stays, is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, growing investments in healthcare infrastructure and services, and the implementation of various government initiatives that encourage healthcare providers and patients to opt for orthopedic biomaterials and procedures, are supporting the market growth.

Key Market Segmentation:

Material Type Insights:

• Ceramics and Bioactive Glasses
• Polymers
• Calcium Phosphate Cement
• Metal
• Composites

Application Insights:

• Orthopedic Implants
• Joint Replacement/Reconstruction
• Orthobiologics
• Viscosupplementation
• Bio-Resorbable Tissue Fixation

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for orthopedic biomaterials. Some of the factors driving the North America orthopedic biomaterials market included the rising geriatric population, various technological advancements, and growing expenditure capacities of consumers.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global orthopedic biomaterials market. Detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., Evonik Industries AG (RAG-Stiftung), Exactech Inc., Globus Medical Inc., Invibio Ltd. (Victrex plc), Koninklijke DSM N.V., Medical Devices Business Services Inc., Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global orthopedic biomaterials market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global orthopedic biomaterials market?
• What is the impact of each driver, restraint, and opportunity on the global orthopedic biomaterials market?
• What are the key regional markets?
• Which countries represent the most attractive orthopedic biomaterials market?
• What is the breakup of the market based on the material type?
• Which is the most attractive material type in the orthopedic biomaterials market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the orthopedic biomaterials market?
• What is the competitive structure of the global orthopedic biomaterials market?
• Who are the key players/companies in the global orthopedic biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Orthopedic Biomaterials Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Material Type

• 6.1 Ceramics and Bioactive Glasses
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Polymers
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Calcium Phosphate Cement
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Metal
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Composites
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Orthopedic Implants
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Joint Replacement/Reconstruction
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Orthobiologics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Viscosupplementation
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Bio-Resorbable Tissue Fixation
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Arthrex Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Berkeley Advanced Biomaterials
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 CAM Bioceramics B.V.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Collagen Matrix Inc.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 CoorsTek Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Evonik Industries AG (RAG-Stiftung)
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Exactech Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Globus Medical Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Invibio Ltd. (Victrex plc)
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
  • 13.3.10 Koninklijke DSM N.V.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Medical Devices Business Services Inc.
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
  • 13.3.12 Stryker Corporation
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
  • 13.3.13 Zimmer Biomet
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.